Drug Type Small molecule drug |
Synonyms Ozagrel Trometamol Concentrated Solution, 奥扎格雷氨丁三醇 |
Target |
Mechanism TXA2 synthase inhibitors(Thromboxane A2 synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (12 Aug 2021), |
Regulation- |
Molecular FormulaC13H12N2O2 |
InChIKeySHZKQBHERIJWAO-AATRIKPKSA-N |
CAS Registry82571-53-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Platelet Aggregation, Spontaneous | CN | 12 Aug 2021 | |
Vasospasm | CN | 12 Aug 2021 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombosis | Phase 2 | CN | 22 Jun 2018 |